ES
EOSAL, A NEW PROCEDURE FOR CNVs DETECTION. NEW ALTERNATIVE ANALYSIS METHOD VERSUS MLPA.
We developed EOSAL-CNV, a new method based on proportional amplification and labeling of amplicons in 1 PCR.
The EOSAL-CNV procedure allowed reliable CNV detection by a single PCR and fragment analysis in a capillary DNA sequencer. The results, published in Clinical Chemistry,show that EOSAL-CNV r...
Leer másSeqplexing has been the beneficiary of the Innodocto grant, within the program Promotion of talent of Generalitat Valenciana
Seqplexing has been the beneficiary of the Innodocto grant, within the talent promotion program
This aid has been granted by the Valencian Agency for Innovation in the year 2018 and aims to support the strengthening and development of the Valencian Innovation System. The amount of the same wi...
Leer másSeqplexing gets authorization as a health center for genetic diagnosis
Seqplexing has obtained the sanitary authorization to offer services as a genetic diagnosis center
Seqplexing has obtained the sanitary authorization to offer services as a genetic diagnosis center .At Seqplexing laboratory genetic analysis will be carried out to detect point mutations and large...
Leer másSequencing Multiplex participates in the investment forum III Encuentro Capital y Ciencia
Sequencing Multiplex participates in the investment forum III Encuentro Capital y Ciencia
Meeting Capital and Sciencehttp://www.pcuv.es/es/encuentrocapitalyciencia/inicio.html...
Leer másSequencing Multiplex, company of the Parc Científic, awarded in the grants
The Valencian company Sequencing Multiplex S.L. has been selected as beneficiary of the "SEED VLC Emprende" Grants in the 2014 edition, offered by the Innovation and Entrepreneur Projects Delegatio...
Leer más
